Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000203178 | SCV000257748 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 1 | 2014-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000479093 | SCV000568956 | likely benign | not specified | 2015-12-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001189183 | SCV001356418 | likely benign | Cardiomyopathy | 2019-04-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000203178 | SCV001685598 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001509130 | SCV001715673 | uncertain significance | not provided | 2019-05-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535510 | SCV004713949 | likely benign | RYR2-related disorder | 2023-10-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |